Silence Therapeutics Plc logo

Silence Therapeutics Plc share price today

(SLN)

Silence Therapeutics Plc share price is $7.07 & ₹602.86 as on 27 Dec 2024, 2.30 'hrs' IST

$7.07

0.07

(1%)

Market is closed - opens 8 PM, 27 Dec 2024

View live Silence Therapeutics Plc share price in Dollar and Rupees. Guide to invest in Silence Therapeutics Plc from India. Also see the sentimental analysis on Indian investors investing in Silence Therapeutics Plc. Get details on the Indian mutual funds that are investing in Silence Therapeutics Plc. Get Analyst recommendations and forecasts along with all the Silence Therapeutics Plc's financials.

Silence Therapeutics Plc share price movements

  • Today's Low: $6.76
    Today's High: $7.14

    Day's Volatility :5.32%

  • 52 Weeks Low: $5.81
    52 Weeks High: $27.72

    52 Weeks Volatility :79.04%

Silence Therapeutics Plc Returns

PeriodSilence Therapeutics PlcSector (Health Care)Index (Russel 2000)
3 Months
-61.64%
-9.0%
0.0%
6 Months
-63.16%
-4.6%
0.0%
1 Year
-58.87%
3.0%
0.0%
3 Years
-70.46%
0.0%
-21.1%

Silence Therapeutics Plc Key Statistics

in dollars & INR

Previous Close
$7.0
Open
$6.93
Today's High
$7.14
Today's Low
$6.76
Market Capitalization
$330.5M
Today's Volume
$278.9K
52 Week High
$27.72
52 Week Low
$5.81
Revenue TTM
$17.9M
EBITDA
$-48.2M
Earnings Per Share (EPS)
$-1.68
Profit Margin
-224.01%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-64.28%

How to invest in Silence Therapeutics Plc from India?

It is very easy for Indian residents to invest directly in Silence Therapeutics Plc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Silence Therapeutics Plc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Silence Therapeutics Plc or SLN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Silence Therapeutics Plc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Silence Therapeutics Plc shares which would translate to 0.121 fractional shares of Silence Therapeutics Plc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Silence Therapeutics Plc, in just a few clicks!

Returns in Silence Therapeutics Plc for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Silence Therapeutics Plc investment value today

Current value as on today

₹43,864

Returns

₹56,136

(-56.14%)

Returns from Silence Therapeutics Plc Stock

₹58,461 (-58.46%)

Dollar Returns

₹2,325 (+2.33%)

Indian investors sentiment towards Silence Therapeutics Plc

-42%

Period: Sep 27, 2024 to Dec 26, 2024. Change in 30 Days versus previous period

Search volume for Silence Therapeutics Plc on INDmoney from India has reduced in the last 30 days as on Dec 27, 2024. -42% less investors are searching Silence Therapeutics Plc in the last 30 days versus the previous period.

Global Institutional Holdings in Silence Therapeutics Plc

  • TCG Crossover Management, LLC

    6.43%

  • Lombard Odier Asset Management USA Corp

    5.64%

  • Redmile Group, LLC

    4.02%

  • Millennium Management LLC

    2.35%

  • Vivo Capital, LLC

    2.34%

  • HHG PLC

    2.30%

Analyst Recommendation on Silence Therapeutics Plc

Buy

    100%Buy

    0%Hold

    0%Sell

Based on 3 Wall street analysts offering stock ratings for Silence Therapeutics Plc(by analysts ranked 0 to 5 stars)

Analyst Forecast on Silence Therapeutics Plc

What analysts predicted

Upside of 659.5%

Current:

$7.07

Target:

$53.70

Insights on Silence Therapeutics Plc

  • Price Movement

    In the last 7 days, SLN stock has moved up by 10.4%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 598.0K → 1.14M (in $), with an average increase of 47.6% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -1.87M → -27.01M (in $), with an average decrease of 401.6% per quarter
  • SLN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 86.0%
  • SLN vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 95.3%
  • Price to Sales

    ForSLN every $1 of sales, investors are willing to pay $16.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Silence Therapeutics Plc Technicals Summary

Sell

Neutral

Buy

Silence Therapeutics Plc is currently in a neutral trading position according to technical analysis indicators.

Silence Therapeutics Plc Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Silence Therapeutics Plc
-8.74%
-63.16%
-58.87%
-70.46%
-70.91%
Regeneron Pharmaceuticals, Inc.
-5.12%
-32.02%
-18.97%
11.91%
91.19%
Biontech Se
-3.72%
42.02%
7.95%
-52.72%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.99%
0.1%
24.29%
44.19%
112.09%
Vertex Pharmaceuticals Incorporated
-12.61%
-12.92%
-0.27%
83.92%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Silence Therapeutics Plc
NA
NA
NA
-0.52
-0.64
-0.22
NA
0.43
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Silence Therapeutics Plc
Buy
$330.5M
-70.91%
NA
-224.01%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
91.19%
17.67
33.61%
Biontech Se
Buy
$27.4B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.1B
86.41%
32.84
-4.51%

About Silence Therapeutics Plc

silence therapeutics develops a new generation of medicines by harnessing the body’s natural mechanism of rna interference, or rnai, within its cells. our proprietary technology can selectively inhibit any gene in the genome, specifically silencing the production of disease-causing proteins. using our enabling delivery systems, we have achieved an additional level of specificity by delivering our therapeutic rna molecules exclusively to target cells. silence’s proprietary rna chemistries and delivery systems are designed to improve the stability of our molecules and enhance effective delivery to target cells, providing a powerful modular technology well suited to tackle life-threatening diseases. for more information, visit us at www.silence-therapeutics.com
Organization
Silence Therapeutics Plc
Employees
109
CEO
Mr. Craig A. Tooman M.B.A.
Industry
Health Technology

Management People of Silence Therapeutics Plc

NameTitle
Mr. Craig A. Tooman M.B.A.
President, CEO & Executive Director
Ms. Rhonda L. Hellums
Executive VP, CFO & Secretary
Dr. Steven J. Romano M.D.
Executive VP and Chief Research & Development Officer
Dr. Marie Wikstrom Lindholm Ph.D.
Chief Scientific Officer
Ms. Gem Gokmen Hopkins
Head of IR & Corporate Communications
Ms. Gianine Esposito
Chief Human Resources Officer
Dr. Barbara A. Ruskin J.D., Ph.D.
Senior VP and Chief Intellectual Property & Innovation Officer
Dr. Eric Floyd M.B.A., M.S., Ph.D.
Senior Vice President of Regulatory Affairs & Quality Assurance
Mr. J.P. Gabriel
Chief Technical Operations Officer
Mr. Curtis Rambaran M.D.
Chief Medical Officer

Important FAQs about investing in Silence Therapeutics Plc from India :

What is Silence Therapeutics Plc share price today?

Silence Therapeutics Plc share price today stands at $7.07, Open: $6.93 ; Previous Close: $7.00 ; High: $7.14 ; Low: $6.76 ; 52 Week High: $27.72 ; 52 Week Low: $5.81. The stock opens at $6.93, after a previous close of $7.00. The stock reached a daily high of $7.14 and a low of $6.76, with a 52-week high of $27.72 and a 52-week low of $5.81.

Can Indians buy Silence Therapeutics Plc shares?

Yes, Indians can invest in the Silence Therapeutics Plc (SLN) from India.

With INDmoney, you can buy Silence Therapeutics Plc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Silence Therapeutics Plc at zero transaction cost.

How can I buy Silence Therapeutics Plc shares from India?

It is very easy to buy Silence Therapeutics Plc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Silence Therapeutics Plc be purchased?

Yes, you can buy fractional shares of Silence Therapeutics Plc with INDmoney app.

What are the documents required to start investing in Silence Therapeutics Plc stocks?

To start investing in Silence Therapeutics Plc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Silence Therapeutics Plc

Today’s highest price of Silence Therapeutics Plc (SLN) is $7.14.

Today’s lowest price of Silence Therapeutics Plc (SLN) is $6.76.

What is today's market capitalisation of Silence Therapeutics Plc

Today's market capitalisation of Silence Therapeutics Plc SLN is 330.5M

What is the 52 Week High and Low Range of Silence Therapeutics Plc

  • 52 Week High

    $27.72

  • 52 Week Low

    $5.81

What are the historical returns of Silence Therapeutics Plc?

  • 1 Month Returns

    -8.74%

  • 3 Months Returns

    -63.16%

  • 1 Year Returns

    -58.87%

  • 5 Years Returns

    -70.91%

Who is the Chief Executive Officer (CEO) of Silence Therapeutics Plc

Mr. Craig A. Tooman M.B.A. is the current Chief Executive Officer (CEO) of Silence Therapeutics Plc.